SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
For the Month of November 2004
BioProgress PLC
(Translation of registrant’s name into English)
Hostmoor Avenue
March, Cambridgeshire
United Kingdom. PE15 0AX
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F þ Form 40-F ¨
Indicate by check mark whether registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes ¨ No þ
If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b):N/A
BioProgress PLC
Form 6-K for the month of November, 2004.
| Contents: | ||
| Enclosure 1. | Press release re: Holdings in BioProgress PLC; | |
| Enclosure 2. | Press release re: Holdings in BioProgress PLC; | |
| Enclosure 3. | Press release re: Additional Listing; | |
| Enclosure 4. | Press release re: Holdings in BioProgress PLC. | |
Enclosure 1.
BioProgress PLC
09 November 2004
SCHEDULE 10
NOTIFICATION OF MAJOR INTERESTS IN SHARES
| 1. | Name of company |
Bioprogress plc
| 2. | Name of shareholder having a major interest |
Man Financial Limited
| 3. | Please state whether notification indicates that it is in respect of holding of the shareholder named in 2 above or in respect of a non-beneficial interest or in the case of an individual holder if is a holding of that person’s spouse or children under the age of 18. |
As above
| 4. | Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them |
Not stated
| 5. | Number of shares/amount of stock acquired |
Not disclosed
| 6. | Percentage of issued class |
Not disclosed
| 7. | Number of shares/amount of stock disposed |
Not disclosed
| 8. | Percentage of issued class |
Not disclosed
| 9. | Class of security |
Ordinary shares of 1p each
| 10. | Date of transaction |
8 November 2004
| 11. | Date company informed |
9 November 2004
| 12. | Total holding following this notification |
4,094,014
| 13. | Total percentage holding of issued class following this notification |
3.51%
| 14. | Any additional information |
| 15. | Name of contact and telephone number for queries |
Elizabeth Edwards, 01354 655674
| 16. | Name and signature of authorised company official responsible for making this notification. |
Elizabeth Edwards Company Secretary
Date of notification: 9 November 2004
Enclosure 2
BioProgress PLC
08 November 2004
SCHEDULE 10
NOTIFICATION OF MAJOR INTERESTS IN SHARES
| 1. | Name of company |
Bioprogress plc
| 2. | Name of shareholder having a major interest |
Man Financial Limited
| 3. | Please state whether notification indicates that it is in respect of holding of the shareholder named in 2 above or in respect of a non- beneficial interest or in the case of an individual holder if it is a holding of that person’s spouse or children under the age of 18. |
As above
| 4. | Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them |
Not stated
| 5. | Number of shares/amount of stock acquired |
Not disclosed
| 6. | Percentage of issued class |
Not disclosed
| 7. | Number of shares/amount of stock disposed |
Not disclosed
| 8. | Percentage of issued class |
Not disclosed
| 9. | Class of security |
Ordinary shares of 1p each
| 10. | Date of transaction |
4 November 2004
| 11. | Date company informed |
5 November 2004
| 12. | Total holding following this notification |
3,994,014
| 13. | Total percentage holding of issued class following this notification |
3.92%
| 14. | Any additional information |
| 15. | Name of contact and telephone number for queries |
Elizabeth Edwards, 01354 655674
| 16. | Name and signature of authorised company official responsible for making this notification. |
Elizabeth Edwards Company Secretary
Date of notification: 5 November 2004
Enclosure 3
BioProgress PLC
14 October 2004
BioProgress PLC (‘BioProgress’ or the ‘Company’)
Pursuant to the exercise of warrants over 225,949 ordinary shares of 1p each in the Company, application has been made for these new ordinary shares (‘New Shares’) to be admitted to the Alternative Investment Market (‘AIM’).
Admission of the New Shares is expected to become effective on 18 October 2004.
14 October 2004
Enclosure 4
BioProgress PLC
28 June 2004
SCHEDULE 10
NOTIFICATION OF MAJOR INTERESTS IN SHARES
| 1. | Name of company |
BioProgress plc
| 2. | Name of shareholder having a major interest |
Barry J Muncaster
| 3. | Please state whether notification indicates that it is in respect of holding of the shareholder named in 2 above or in respect of a non-beneficial interest or in the case of an individual holder if it is a holding of that person’s spouse or children under the age of 18. |
As above
| 4. | Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them |
Not disclosed
| 5. | Number of shares/amount of stock acquired |
Not disclosed
| 6. | Percentage of issued class |
Not disclosed
| 7. | Number of shares/amount of stock disposed |
Not disclosed
| 8. | Percentage of issued class |
N/A
| 9. | Class of security |
Ordinary shares of 1p each
| 10. | Date of transaction |
Not disclosed
| 11. | Date company informed |
28 June 2004
| 12. | Total holding following this notification |
3,398,634
| 13. | Total percentage holding of issued class following this notification |
2.9%
| 14. | Any additional information |
| 15. | Name of contact and telephone number for queries |
Elizabeth Edwards 01354 655674
| 16. | Name and signature of authorised company official responsible for making this notification. |
Elizabeth Edwards, Company Secretary
Date of notification: 28 June 2003
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
BIOPROGRESS PLC | ||
/s/ ELIZABETH EDWARDS | ||
Dated: November 16, 2004 | Elizabeth Edwards | |
Chief Financial Officer | ||
